Midatech Pharma PLC Stock News

Midatech Pharma plc (NASDAQ:MTP) saw a significant drop in short interest during the month of November. As of November 15th, there was short interest totalling 122,800 shares, a drop of 31.3% from the October 31st total of 178,700 shares. Based on an average daily volume of 99,200 shares, the short-interest ratio is presently 1.2 days. []

Midatech Pharma Plc - ADR (MTP) shares closed today at 0.4% above its 52 week low of $1.47, giving the company a market cap of $29M. The stock is currently down 21.1% year-to-date, down 19.4% over the past 12 months, and down 99.0% over the past five years. This week, the Dow Jones Industrial Average fell 1.9%, and the S&P 500 fell 2.1%. Trading Activity Trading volume this week was 10.0% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Midatech Pharma plc (NASDAQ:MTP) saw a significant growth in short interest in the month of October. As of October 29th, there was short interest totalling 178,700 shares, a growth of 19.1% from the October 14th total of 150,000 shares. Based on an average daily trading volume, of 98,300 shares, the days-to-cover ratio is presently 1.8 []

Shares of Midatech Pharma plc (NASDAQ:MTP) fell 5% on Thursday . The stock traded as low as $1.50 and last traded at $1.53. 170,785 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 929,909 shares. The stock had previously closed at $1.61. The company has a fifty day []

Midatech Pharma plc (MTP) CEO Stephen Stamp on Q2 2021 Results - Earnings Call Transcript

ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 6, 2021 / Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of med

Midatech Pharma plc (NASDAQ: MTP) has raised £10 million from equity placing to fund its product development pipeline. Approximately 35 million new shares in the Company were issued at 28.5p each,

Shares of MTP stock are skyrocketing on Thursday following news of positive results from a portion of Midatech Pharma's technology. The post MTP Stock: The Big Midatech Pharma News That Has Shares Roc

Midatech Pharma PLC (LON: MTPH) has issued an update which has injected life into its share price. The biotech company announced what it called "breakthrough" data relating to its Q-Sphera technology

Midatech Pharma PLC (NASDAQ: MTP) has announced a breakthrough in vitro data utilizing Q-Sphera technology and progress across multiple other programs. The technology showed potential to formulate pr

The stock price of Midatech Pharma plc (NASDAQ: MTP) increased by over 35% pre-market. This is why it happened.

Breakthrough data on the successful encapsulation of a biologic using Q-Sphera technology Significant progress across multiple other R&D programmes ABINGDON, OXFORDSHIRE/ ACCESSWIRE / June 17, 2021 /

ABINGDON, UK / ACCESSWIRE / June 9, 2021 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, will

Preliminary Results for the Year Ended 31 December 2020 ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 30, 2021 / Midatech Pharma PLC (AIM:MTPH.L); (NASDAQ:MTP), a drug delivery technology company focused

Non-binding Heads of Terms for Co-development of MTX110; Unaudited Headline Results for the Year Ended 31 December 2020 ABINGDON, UK / ACCESSWIRE / March 25, 2021 / Midatech Pharma PLC (AIM:MTPH.L)(